Sarah Stark Casagrande1, Catherine C Cowie2, Saul M Genuth3. 1. Social & Scientific Systems, Inc., Silver Spring. Electronic address: scasagrande@s-3.com. 2. Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland. 3. Division of Clinical and Molecular Endocrinology, Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Abstract
BACKGROUND: Early detection of type 2 diabetes has the potential to prevent complications, but the prevalence of opportunistic screening is unknown. PURPOSE: To describe the prevalence of diabetes screening by demographic and diabetes-related factors and to determine predictors of screening among a representative U.S. population without self-reported diabetes. METHODS: Cross-sectional data were obtained from the 2005-2010 National Health and Nutrition Examination Survey (n=15,125) and 2006 National Health Interview Survey (n=21,519). Participants were aged ≥20 years and self-reported having a diabetes screening test in the past 3 years. Diabetes screening prevalence was analyzed according to risk factors recommended by the American Diabetes Association. Logistic regression was used to determine significant predictors of diabetes screening. Analysis was conducted in 2012-2013. RESULTS: The prevalence of having a blood test for diabetes in the past 3 years was 42.1% in 2005-2006, 41.6% in 2007-2008, and 46.8% in 2009-2010. This prevalence increased with age and was higher for women, non-Hispanic whites, and those with more education and income (p<0.001 for all). BMI ≥25, age ≥45 years, having a relative with diabetes, hypertension, glycosylated hemoglobin ≥5.7%, and cardiovascular disease history were significant predictors of screening. For each additional risk factor, the likelihood of screening increased by 51%. CONCLUSIONS: Nearly half of the adult population reported having a diabetes screening test. However, testing was less prevalent in minorities and those with lower socioeconomic status. Public health efforts to address these deficiencies in screening are needed.
BACKGROUND: Early detection of type 2 diabetes has the potential to prevent complications, but the prevalence of opportunistic screening is unknown. PURPOSE: To describe the prevalence of diabetes screening by demographic and diabetes-related factors and to determine predictors of screening among a representative U.S. population without self-reported diabetes. METHODS: Cross-sectional data were obtained from the 2005-2010 National Health and Nutrition Examination Survey (n=15,125) and 2006 National Health Interview Survey (n=21,519). Participants were aged ≥20 years and self-reported having a diabetes screening test in the past 3 years. Diabetes screening prevalence was analyzed according to risk factors recommended by the American Diabetes Association. Logistic regression was used to determine significant predictors of diabetes screening. Analysis was conducted in 2012-2013. RESULTS: The prevalence of having a blood test for diabetes in the past 3 years was 42.1% in 2005-2006, 41.6% in 2007-2008, and 46.8% in 2009-2010. This prevalence increased with age and was higher for women, non-Hispanic whites, and those with more education and income (p<0.001 for all). BMI ≥25, age ≥45 years, having a relative with diabetes, hypertension, glycosylated hemoglobin ≥5.7%, and cardiovascular disease history were significant predictors of screening. For each additional risk factor, the likelihood of screening increased by 51%. CONCLUSIONS: Nearly half of the adult population reported having a diabetes screening test. However, testing was less prevalent in minorities and those with lower socioeconomic status. Public health efforts to address these deficiencies in screening are needed.
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Edward W Gregg; Earl S Ford; Linda S Geiss; Kathleen E Bainbridge; Judith E Fradkin Journal: Diabetes Care Date: 2010-01-12 Impact factor: 19.112
Authors: Simon J Griffin; Knut Borch-Johnsen; Melanie J Davies; Kamlesh Khunti; Guy E H M Rutten; Annelli Sandbæk; Stephen J Sharp; Rebecca K Simmons; Maureen van den Donk; Nicholas J Wareham; Torsten Lauritzen Journal: Lancet Date: 2011-06-24 Impact factor: 79.321
Authors: Yiling J Cheng; Giuseppina Imperatore; Linda S Geiss; Jing Wang; Sharon H Saydah; Catherine C Cowie; Edward W Gregg Journal: Diabetes Care Date: 2013-05-01 Impact factor: 19.112
Authors: Udoka Obinwa; Adriana Pérez; Ildiko Lingvay; Luigi Meneghini; Ethan A Halm; Michael E Bowen Journal: Diabetes Care Date: 2020-03-05 Impact factor: 19.112
Authors: Sarah Stark Casagrande; Andy Menke; Larissa Aviles-Santa; Linda C Gallo; Martha L Daviglus; Gregory A Talavera; Sheila F Castañeda; Krista Perreira; Matthew Shane Loop; Wassim Tarraf; Hector M González; Catherine C Cowie Journal: Diabetes Res Clin Pract Date: 2018-11-09 Impact factor: 5.602
Authors: Tainayah W Thomas; Carol Golin; Carmen D Samuel-Hodge; M Sue Kirkman; Shelley D Golden; Alexandra F Lightfoot Journal: Prev Med Date: 2021-04-27 Impact factor: 4.637